Mechanism of minimally modified LDL-mediated induction of serum amyloid A gene in monocyte/macrophage cells

DNA and Cell Biology

Volumn 18, Issue 1, 1999, Pages 65-73

  Ray, Bimal K ^a   Chatterjee, Sabarni ^a   Ray, Alpana ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; ANTIBODY; CD36 ANTIGEN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; RNA; SCAVENGER RECEPTOR; TAMOXIFEN; TRANSCRIPTION FACTOR;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MONOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

ANTIGENS, CD36; BLOTTING, NORTHERN; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MONOCYTES; MUTATION; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; SERUM AMYLOID A PROTEIN; TAMOXIFEN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0032908017     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999315637     Document Type: Article

References (33)

1. ALAM, T., AN, M.R., and PAPACONSTANTINOU, J. (1992). Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J. Biol. Chem. 267, 5021-5024.
2. BERLINER, J., NAVAB, M., FOGELMAN, A., FRANK, J., DEMER, L., EDWARDS, P., WATSON, A., and LUSIS, A. (1995). Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation 91, 2488-2496.
3. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single step method of RNA isolation by acidic guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
5. CHRISTY, R.J., YANG, V.W., NTAMBI, J.M., GEIMAN, D.E., LANDSCHULZ, W.H., FRIEDMAN, A.D., NAKABEPPU, Y., KELLY, T.J., and LANE, M.D. (1989). Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev. 3, 1323-1335.
6. COETZEE, G.A., STRACHAN, A.F., van der WESTHUYZEN, D.R., HOPPE, H.C., JEENAH, M.S., and DeBEER, F.C. (1986). Serum amyloid A containing human high density lipoprotein 3. J. Biol. Chem. 261, 9644-9651.
7. FRIEDMAN, A.D., LANDSCHULZ, W.H., and McKNIGHT, S.L. (1989). CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev. 3, 1314-1322.
8. HAJJAR, D.P., and HABERLAND, M.E. (1997). Lipoprotein trafficking in vascular cells: molecular Trojan horses and cellular saboteurs. J. Biol. Chem. 272, 22975-22978.
9. JIANG, S.-L., LOZANSKI, G., SAMOLS, D., and KUSHNER, I. (1995). Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1β involves both transcriptional and posttranscriptional mechanisms. J. Immunol. 154, 825-831.
10. p) binds cholesterol and modulates cholesterol flux. J. Lipid Res. 36, 37-46.
11. LIAO, F., ANDALIBI, A., QIAO, J.H., ALLAYEE, H., FOGELMAN, A.M., and LUSIS, A.J. (1994). Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin. Invest. 94, 877-884.
12. LIAO, F., BERLINER, J.A., MEHRABIAN, M., NAVAB, M., DEMER, L., LUSIS, A.J., and FOGELMAN, A.M. (1991). Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87, 2253-2257.
13. LOWELL, C.A., STEARMAN, R.S., and MORROW, J.F. (1986). Structure of the murine serum amyloid A gene family. J. Biol. Chem. 261, 8453-8461.
14. LUCKOW, B., and SCHUTZ, G. (1987). CAT constructions with multiple unique restriction sites for the functional analysis of eucaryotic promoters and regulatory elements. Nucleic Acids Res. 15, 5490.
15. LUSIS, A.J., and NAVAB, M. (1993). Lipoprotein oxidation and gene expression in the artery wall: new opportunities for pharmacologic intervention in atherosclerosis. Biochem. Pharmacol. 46, 2119-2126.
16. MALLE, E., STEINMETZ, A., and RAYNES, J.G. (1993). Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 102, 131-146.
17. MANDRUP, S., and LANE, M.D. (1997). Regulating adipogenesis. J. Biol. Chem. 272, 5367-5370.
18. MEEK, R.L., UREILI-SHOVAL, S., and BENDITT, E.P. (1994). Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA, 91, 3186-3190.
19. METZ, R., and ZIFF, E. (1991). cAMP stimulates the C/EBP-related transcription factor rNFIL6 to translocate to the nucleus and induce c-fos transcription. Genes Dev. 5, 1754-1766.
20. NAKAJIMA, T., KINOSHITA, S., SASAGAWA, T., SASAKI, K., NARUTO, M., KISHIMOTO, T., and AKIRA, S. (1993). Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 90, 2207-2211.
21. NAVAB, M., BERLINER, J., WATSON, A., HAMA, S., TERRITO, M., LUSIS, A., SHIH, D., VAN LETEN, B., FRANK, J., DEMER, L., EDWARDS, P., and FOGELMAN, A. (1996). The yin and yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. 16, 831-842.
22. RAY, A., HANNINK, M., and RAY, B.K. (1995). Concerted participation of NF-κB and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J. Biol. Chem. 270, 7365-7374.
23. RAY, A., and RAY, B.K. (1994). Serum amyloid A gene expression under acute-phase condition involves participation of inducible C/EBP-β and C/EBP-δ and their activation by protein phosphorylation. Mol. Cell. Biol. 14, 4324-4332.
24. RAY, A., and RAY, B.K. (1996). A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells. Mol. Cell. Biol. 16, 1584-1594.
25. RAY, A., and RAY, B.K. (1997a). Serum amyloid A gene expression level in liver in response to different inflammatory agents is dependent upon the nature of activated transcription factors. DNA Cell Biol. 16, 1-7.
26. RAY, B.K., and RAY, A. (1997b). Induction of serum amyloid A (SAA) gene by SAA-activating sequence-binding factor (SAF) in monocyte/macrophage cells. J. Biol. Chem. 272, 28948-28953.
27. RAY, B.K., and RAY, A. (1997c). Involvement of SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Biochemistry 36, 4662-4668.
28. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
29. SILVA, I.D.C.G., SALICIONI, A.M., RUSSO, I.H., HIGGY, N.A., GEBRIM, L.H., and RUSSO, J. (1997). Tamoxifen downregulates CD36 messenger RNA levels in normal and neoplastic human breast tissues. Cancer Res. 57, 378-381.
30. SIPE, J.D. (1994). Amyloidosis. Crit. Rev. Clin. Lab. Sci. 31, 325-354.
31. STEINBERG, D. (1997). Oxidative modification of LDL and atherogenesis. Circulation 95, 1062-1071.
32. STEINBERG, D., PARTHASARATHY, S., CAREW, T.E., KHOO, J.C., and WITZTUM, J.L. (1989). Beyond cholesterol: modifications of low-density lipoprotein that increase atherogenicity. N. Engl. J. Med. 320, 915-924.
33. STEINMETZ, A., HOCKE, G., SALIE, R., PUCHOIS, P., and FRUCHART, J.C. (1989). Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim. Biophys. Acta 1006, 173-178.